What Are Peptides?
Peptides are short chains of amino acids — the fundamental building blocks of all proteins — linked together by peptide bonds. Whereas full proteins may contain hundreds or thousands of amino acid residues, bioactive peptides typically comprise between two and fifty residues, a compact architecture that allows them to traverse cellular membranes and bind selectively to receptor sites with extraordinary precision.
Within the human body, endogenous peptides serve as master regulators: they act as signalling molecules, hormones, neurotransmitters, and modulators of the immune cascade. Insulin, oxytocin, and the body's own opioid peptides are all members of this class. When endogenous peptide signalling is disrupted by age, injury, or metabolic stress, targeted exogenous peptides can restore physiological balance with a specificity that small-molecule pharmaceuticals rarely achieve.
What distinguishes therapeutic peptides from synthetic compounds is their structural homology with the body's own proteins. Because they mirror natural sequences, they are recognised and processed by native enzymatic pathways, reducing the risk of off-target toxicity. This biological compatibility, combined with the capacity for rational sequence design, places precision peptides at the frontier of modern regenerative medicine.
Peptide Chain Schematic
Seven-residue peptide with side chains and terminal groups
Mechanisms of Action
Peptide therapeutics exert their effects through three primary biological axes, each underpinned by distinct receptor pharmacology and downstream signalling.
Tissue Repair & Regeneration
Recovery peptides such as BPC-157 and TB-500 activate growth factor receptors, stimulate angiogenesis, and upregulate genes involved in cellular proliferation. They accelerate the resolution of inflammation and promote fibroblast migration into wound beds, restoring structural integrity to damaged tissue with a velocity that exceeds unaided healing by a measurable factor.
Telomere Biology & Cellular Ageing
Longevity peptides such as Epithalon and Thymosin Alpha-1 operate at the epigenetic layer. Epithalon stimulates telomerase reverse transcriptase (TERT), lengthening telomeric caps and extending the Hayflick limit of somatic cells. Thymosin Alpha-1 modulates toll-like receptor signalling and restores age-related thymic involution, maintaining immunological fitness in senescent tissue.
Metabolic Optimisation
GLP-1 and dual GIP/GLP-1 receptor agonists (Semaglutide, Tirzepatide) bind incretin receptors in the pancreas, hypothalamus, and gut. The result is glucose-dependent insulin secretion, suppression of glucagon, delayed gastric emptying, and centrally mediated satiety — a multi-axis metabolic recalibration that substantially improves body composition and cardiometabolic risk markers.
Purity Standards
Every batch is independently tested before release. Our specifications exceed industry minimums at every parameter — not as a marketing claim, but as an operational non-negotiable.
| Parameter | Industry Standard | SYNTHEXA Grade |
|---|---|---|
| Purity | ≥98% | >99.8% |
| HPLC Verified | ✓ | ✓ |
| Endotoxin | <1 EU/mg | <0.1 EU/mg |
| Sterility Tested | ✓ | ✓ |
| Mass Spectrometry | Selected | Every batch |
| Moisture Content | <8% | <5% |
Peer Research
Our formulations are grounded in published, peer-reviewed science. A selection of foundational studies:
BPC-157 accelerates healing of collagenous structures in tendons and ligaments
2010Journal of Physiology — Paris
Demonstrated that BPC-157 promoted tendon-to-bone healing in rats, with histological evidence of improved collagen organisation and reduced inflammatory infiltrate. Proposed FAK-paxillin pathway as primary mechanism.
Thymosin β4 promotes dermal healing and reduces scarring in full-thickness wounds
2012Annals of the New York Academy of Sciences
TB-500's actin-sequestering domain was shown to recruit progenitor cells to wound sites, accelerate re-epithelialisation, and modulate MMP activity to reduce fibrotic scarring — effects reproducible across multiple tissue models.
Epithalon activates telomerase and elongates telomeres in human somatic cells in vitro
2003Bulletin of Experimental Biology and Medicine
Landmark study demonstrating that the tetrapeptide AEDG (Epithalon) directly activates telomerase in human fetal fibroblasts, increasing mean telomere length and extending the proliferative lifespan of cells beyond the conventional Hayflick limit.
Ready to begin your protocol?
Explore the Collection